Testing effectiveness (Phase 2)Ended earlyNCT02600286What this trial is testingUlipristal Acetate In Disease Charcot-Marie-Tooth Type of 1AWho this might be right forCMT1A University Hospital, Strasbourg, France 23
Large-scale testing (Phase 3)Study completedNCT02579759What this trial is testingPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A Patients (PLEO-CMT)Who this might be right forCharcot-Marie-Tooth Disease Type 1A Pharnext S.C.A. 323
Early research (Phase 1)Study completedNCT06328712What this trial is testingEvaluate the Safety and Efficacy of EN001 in Patients With Charcot-Marie-Tooth Disease Type 1AWho this might be right forCharcot-Marie-Tooth Disease Type 1A ENCell 6
Large-scale testing (Phase 3)UnknownNCT01289704What this trial is testingTreadmill, Stretching and Proprioceptive Exercise (TreSPE) Rehabilitation Program for Charcot-Marie-Tooth Neuropathy Type 1A (CMT1A)Who this might be right forCharcot-Marie-Tooth DiseaseCharcot-Marie-Tooth Disease Type 1A University of Genova 92
Not applicableNot Yet RecruitingNCT07066683What this trial is testingPilot Study to Evaluate Fatigue and Fatigability Profiles and Their Impact on Walking and Balance in Patients With Charcot-Marie-Tooth Type 1A Disease Using a Global Approach in Comparison to Healthy Volunteers.Who this might be right forCharcot-Marie-Tooth Type 1A University Hospital, Strasbourg, France 44
Not applicableStudy completedNCT05142059What this trial is testingFall Risk Assessment in a Population of Charcot-Marie-Tooth Disease Type 1A (CMT 1A) by Timed Up and Go TestWho this might be right forCharcot-Marie-Tooth Type 1A Neuropathy University Hospital, Clermont-Ferrand 42
Not applicableActive Not RecruitingNCT02596191What this trial is testingTools for Therapeutic Evaluation in Charcot-Marie-Tooth Disease Type 1A: Outcome Measures and BiomarkersWho this might be right forCharcot-Marie-Tooth Disease Type 1A Assistance Publique Hopitaux De Marseille 80
Not applicableLooking for participantsNCT07049588What this trial is testingIdentification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A DiseaseWho this might be right forCharcot-Marie-Tooth Disease Type 1A Assistance Publique Hopitaux De Marseille 55
Not applicableStudy completedNCT05687474What this trial is testingBaby Detect : Genomic Newborn ScreeningWho this might be right forCongenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more Centre Hospitalier Universitaire de Liege 6,824
Early research (Phase 1)Looking for participantsNCT07140614What this trial is testingA First in Human Study to Assess the Safety, Tolerability, and Pharmacokinetics of EDK060 in Adults With CMT1A.Who this might be right forCharcot-Marie-Tooth Disease, Type 1A Novartis Pharmaceuticals 28
Large-scale testing (Phase 3)Active Not RecruitingNCT03023540What this trial is testingAssessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1AWho this might be right forCharcot-Marie-Tooth Disease, Type IA Pharnext S.C.A. 187
Testing effectiveness (Phase 2)Study completedNCT00271635What this trial is testingAscorbic Acid Treatment in CMT1A Trial (AATIC)Who this might be right forCharcot-Marie-Tooth DiseaseHereditary Motor and Sensory Neuropathies Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 13
Large-scale testing (Phase 3)Study completedNCT00484510What this trial is testingHigh Dose Ascorbic Acid Treatment of CMT1AWho this might be right forCharcot-Marie-Tooth Disease, Type Ia Wayne State University 110
Testing effectiveness (Phase 2)Study completedNCT02967679What this trial is testingSERENDEM : MD1003 in Patients Suffering From Demyelinating Neuropathies, an Open Label Pilot StudyWho this might be right forChronic Inflammatory Demyelinating PolyneuropathyPeripheral NeuropathyCharcot-Marie-Tooth Disease+3 more MedDay Pharmaceuticals SA 15
Early research (Phase 1)Study completedNCT05333406What this trial is testingDetermine the Safety and Dose of EN001 in Patients With Charcot-Marie-Tooth Disease (CMT) Type 1AWho this might be right forCharcot-Marie-Tooth Disease, Type IA ENCell 9
Not applicableLooking for participantsNCT06845644What this trial is testingLongitudinal Quantitative Neuromuscular MRI in Neuropathic PatientsWho this might be right forCharcot-Marie-Tooth Neuropathy Type 1AHereditary Transthyretin Amyloid NeuropathyAcquired Demyelinating Neuropathy Assistance Publique Hopitaux De Marseille 120
Large-scale testing (Phase 3)Active Not RecruitingNCT04762758What this trial is testingPhase III Trial Assessing the Efficacy and Safety of PXT3003 in CMT1A PatientsWho this might be right forCharcot-Marie-Tooth Disease Pharnext S.C.A. 350
Testing effectiveness (Phase 2)Not Yet RecruitingNCT03520751What this trial is testingPhase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1AWho this might be right forCharcot-Marie-Tooth Neuropathy Type 1A Nationwide Children's Hospital 3
Not applicableStudy completedNCT01750710What this trial is testingCorrelation Between Clinical and Electrophysiological Phenotypes in a Population of Patients With Neuropathy Charcot-Marie-Tooth Disease Type 1AWho this might be right forCharcot-Marie-Tooth Type 1A Neuropathy University Hospital, Clermont-Ferrand 37
Testing effectiveness (Phase 2)Study completedNCT01401257What this trial is testingPhase II, Randomized, Placebo-controlled Trial in Patients With Charcot-marie-tooth Disease Type 1AWho this might be right forCharcot-Marie-Tooth DiseaseHereditary Neuropathy With Liability to Pressure PalsiesGenetic Disorders Pharnext S.C.A. 80